$0.200
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MTNB Prediction & Forecast by Similar Chart Analysis
Alphio's MTNB stock price prediction model matches the current Matinas BioPharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.20 (-0.63%). The 1-week path is $0.20 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Matinas BioPharma Holdings Inc Stock?
Matinas BioPharma Holdings Inc is not a good buy right now due to its declining financial health and significant operational challenges. The current price is $0.20, and the company has reported a staggering year-to-date change of -67.74%. Additionally, the RSI is at 38.803, indicating that the stock is in a bearish trend. The company has also faced compliance challenges with the NYSE due to stockholders' equity falling below $4 million, which is a significant risk. Furthermore, the forward P/E ratio is 0, indicating no expected earnings growth, and the company has reported consistent losses, with a net income of -$4.27 million in Q3 2024. Overall, the combination of these factors suggests that now is not the right time to invest in this asset.
MTNB stock price ended at $0.20 on Friday, after rising 0.00%
Matinas BioPharma Holdings Inc (MTNB) last closed at $0.2, gaining +0.00%. These facts feed the 1-day and 1-week MTNB price prediction above.
Analyst Consensus
Matinas BioPharma Holdings Inc (MTNB): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Matinas BioPharma Holdings Inc (MTNB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MTNB, ranked by similarity.
Seasonality analysis for MTNB
Historically the probability of a positive August return for MTNB is 33.33%. June offers the highest probability of a positive month at 65.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MTNB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.68 | $0.87 | $0.96 | +335.23% |
| Sep 2026 | $1.02 | $1.16 | $1.21 | +479.60% |
| Oct 2026 | $0.91 | $0.96 | $1.17 | +377.57% |
| Nov 2026 | $0.84 | $0.86 | $1.08 | +328.40% |
| Dec 2026 | $0.95 | $1.00 | $1.12 | +401.10% |
In 2026, Matinas BioPharma Holdings Inc (MTNB) is projected to range from $0.68 to $1.21.
Matinas BioPharma Holdings Inc 2026 monthly forecast
In Aug 2026, Matinas BioPharma Holdings Inc is projected to average $0.87, with a low of $0.68 and high of $0.96.
In Sep 2026, Matinas BioPharma Holdings Inc is projected to average $1.16, with a low of $1.02 and high of $1.21.
In Oct 2026, Matinas BioPharma Holdings Inc is projected to average $0.96, with a low of $0.91 and high of $1.17.
In Nov 2026, Matinas BioPharma Holdings Inc is projected to average $0.86, with a low of $0.84 and high of $1.08.
In Dec 2026, Matinas BioPharma Holdings Inc is projected to average $1.00, with a low of $0.95 and high of $1.12.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.